ONMD
OneMedNet Corp
OneMedNet Corp insider trading
Insiders at OneMedNet Corp have been buying its stock on the open market. The largest purchase in the last 30 days was Yu Jeffrey (Chief Medical Officer · Director) buying $90K of ONMD, filed Sep 14, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $90K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 10, 2026
From SEC filings · last 30 days
Recent ONMD insider transactions
Yu JeffreyChief Medical Officer · Director
Bought 142,857 sh at $0.63 · Sep 10, 2026
$90K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
ONMD insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded ONMD on the open market: 46 purchases worth $4.2M and 2 sales worth $218.3K. In the last four quarters alone: 30 purchases ($2.9M) and 2 sales ($218.3K), by 4 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$1.6M9 buys | — | |
| Q1 2026 | +$500K1 buy | — | |
| Q4 2025 | +$30.5K1 buy | −$218.3K2 sales | |
| Q3 2025 | +$765.2K19 buys | — | |
| Q2 2025 | +$1.2M4 buys | — | |
| Q1 2025 | — | — | |
| Q4 2024 | +$1.7K3 buys | — | |
| Q3 2024 | +$9.2K9 buys | — |
- Largest purchase
- +$750K of ONMD by Yu Jeffrey (Chief Medical Officer · Director) on Apr 01, 2026.
- Largest sale
- −$144.4K of ONMD by Green Aaron (Chief Executive Officer · Director) on Oct 22, 2025.
Open-market transactions through Jun 30, 2026most recent first
Yu Jeffrey
Chief Medical Officer · Director
+$100K
Jun 23, 2026
158,730 sh · $0.63
Green Aaron
Chief Executive Officer · Director
+$20.9K
Jun 23, 2026
36,651 sh · $0.57
Yu Jeffrey
Chief Medical Officer · Director
+$100K
Jun 16, 2026
172,414 sh · $0.58
Green Aaron
Chief Executive Officer · Director
+$10.1K
Jun 15, 2026
18,702 sh · $0.54
Kosasa Thomas
Director · 10% Owner
+$100K
Jun 12, 2026
158,730 sh · $0.63
Green Aaron
Chief Executive Officer · Director
+$20.7K
Jun 12, 2026
36,920 sh · $0.56
Kosasa Thomas
Director · 10% Owner
+$250K
May 18, 2026
268,817 sh · $0.93
Kosasa Thomas
Director · 10% Owner
+$250K
Apr 23, 2026
280,898 sh · $0.89
Yu Jeffrey
Chief Medical Officer · Director
+$750K
Apr 01, 2026
903,614 sh · $0.83
Kosasa Thomas
Director · 10% Owner
+$500K
Feb 06, 2026
595,238 sh · $0.84
Green Aaron
Chief Executive Officer · Director
−$73.9K
Nov 18, 2025
61,555 sh · $1.20
Green Aaron
Chief Executive Officer · Director
−$144.4K
Oct 22, 2025
64,767 sh · $2.23
Casaburi Eric
Director
+$30.5K
Oct 15, 2025
10,000 sh · $3.05
Yu Jeffrey
Chief Medical Officer · Director
+$1.3K
Sep 25, 2025
1,250 sh · $1.03
Yu Jeffrey
Chief Medical Officer · Director
+$17.5K
Sep 24, 2025
17,200 sh · $1.02
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Yu JeffreyChief Medical Officer · Director | 158,730 | $0.63 | +$100K |
| Jun 23, 2026 | Green AaronChief Executive Officer · Director | 36,651 | $0.57 | +$20.9K |
| Jun 16, 2026 | Yu JeffreyChief Medical Officer · Director | 172,414 | $0.58 | +$100K |
| Jun 15, 2026 | Green AaronChief Executive Officer · Director | 18,702 | $0.54 | +$10.1K |
| Jun 12, 2026 | Kosasa ThomasDirector · 10% Owner | 158,730 | $0.63 | +$100K |
| Jun 12, 2026 | Green AaronChief Executive Officer · Director | 36,920 | $0.56 | +$20.7K |
| May 18, 2026 | Kosasa ThomasDirector · 10% Owner | 268,817 | $0.93 | +$250K |
| Apr 23, 2026 | Kosasa ThomasDirector · 10% Owner | 280,898 | $0.89 | +$250K |
| Apr 01, 2026 | Yu JeffreyChief Medical Officer · Director | 903,614 | $0.83 | +$750K |
| Feb 06, 2026 | Kosasa ThomasDirector · 10% Owner | 595,238 | $0.84 | +$500K |
| Nov 18, 2025 | Green AaronChief Executive Officer · Director | 61,555 | $1.20 | −$73.9K |
| Oct 22, 2025 | Green AaronChief Executive Officer · Director | 64,767 | $2.23 | −$144.4K |
| Oct 15, 2025 | Casaburi EricDirector | 10,000 | $3.05 | +$30.5K |
| Sep 25, 2025 | Yu JeffreyChief Medical Officer · Director | 1,250 | $1.03 | +$1.3K |
| Sep 24, 2025 | Yu JeffreyChief Medical Officer · Director | 17,200 | $1.02 | +$17.5K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check ONMD — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
OneMedNet Corp is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are ONMD insiders buying or selling?
- Between Sep 10, 2026 and Sep 10, 2026, 1 OneMedNet Corp insider made 1 open-market purchase worth $90K and no sales, a net purchase of $90K.
- How much ONMD stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 4 OneMedNet Corp insiders made 46 open-market purchases worth $4.2M and 2 sales worth $218.3K. In the four quarters to Jun 30, 2026: 30 purchases ($2.9M) and 2 sales ($218.3K). The largest purchase was Yu Jeffrey buying $750K on Apr 01, 2026. The largest sale was Green Aaron selling $144.4K on Oct 22, 2025.
- What was the largest recent ONMD insider trade?
- Yu Jeffrey (Chief Medical Officer · Director) bought $90K of ONMD stock on Sep 10, 2026 at about $0.63 a share.
- When did an insider last buy ONMD shares?
- The most recent open-market purchase on file is Yu Jeffrey (Chief Medical Officer · Director) buying $90K on Sep 10, 2026.
- Where does ONMD insider trading data come from?
- From the Form 4 filings OneMedNet Corp's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in ONMD and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.